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This study investigated the role of the endothelium and angiotensin II (Ang II) in regulating medial smooth muscle cell
(SMC) proliferation. PH]-thymidine incorporation into medial SMC of rat arteries was examined in vivo, using ballooned
rat carotid arteries, as well as in vitro, using cultures of aortic tissue rings (organoids). In vivo, maximal medial pH]-thymi-
dine incorporation occurred within 3 days post-ballooning. In endothelium-denuded organoids, maximum medial DNA
synthesis was achieved after 7 days of culture. fHJ-thymidine-labelling of SMC in intact organoids (with endothelium)
increased minimally during culture, indicating that the endothelium provided protection with respect to medial proliferation
under basal conditions (culture in the presence of1% plasma-derived serum). Inclusion of 10~7M Ang-II significantly ele-
vated medial fHJ-thymidine incorporation above that in control cultures. The stimulatory effect of Ang II was much more
pronounced in intact organoids than in endothelium-denuded organoids, indicating synergistic growth regulation by Ang II
and endothelium-derived factors. When organoids were cultured in the combined presence of Ang II and the ACE inhibitor
cilazaprilat, labelling indices of intact organoids were also significantly increased above control, but to a lower level than
those obtained in the presence of Ang II alone. However, for endothelium-denuded organoids, medial PHJ-thymidine incor-
poration in the combined presence of Ang II and cilazaprilat was not significantly different from that in untreated controls.
Thus, cilazaprilat exerts both endothelium-dependent and endothelium-independent negative regulatory effects on medial
SMC proliferation.
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tia. Aortae were sliced into —0-5 cm-wide rings, either left
intact or mechanically denuded of the endothelium, and
cultured as free-floating segments (aortic organoids) in
OptiMEM (Gibco/BRL) supplemented with 1% plasma-
derived serum (PDS, prepared as described by Ross and
Kariya'71) with medium changes every second day. The free
floating aortic organoids were maintained for up to at least
14 days without any occurrence of explant culture.
Compared with intact aortic rings, de-endothelialized seg-
ments did not exhibit relaxation responses to acetylcholine
or histamine but did retain a full depolarization-induced
contractile response. Organoids were cultured in the
absence and continuous presence of 10~7M Ang II and
without or with inclusion of 0-1 mg.ml"' cilazaprilat. Ang II
was added twice daily throughout the culture period. For
[3H]-thymidine labelling, organoids were incubated with
1 /iCi.ml"1 of radiolabelled nucleotide for the last 48 h of
the different culture periods. The minor proliferation
response (assessed by cell enumeration as described previ-
ously'81) of cultured rat aortic smooth muscle cells to 1 %
PDS (1-3-fold increase in cell number after 10 days in cul-
ture) assured that PDS preparations used were essentially
mitogen-free.
HISTOCHEMISTRY
Organoids were sliced in half and embedded in Tissue-
Tek OCT (Miles Laboratories Inc., Naperville, IL, U.S.A.)
with the newly cut edges facing upwards. Mounted tissue
was frozen rapidly in an isopentane bath in liquid nitrogen.
Sections of ~5 /im were cut in a freezing microtome,
applied to polylysine-coated slides, dried and stored at
—70°C. Sections were developed and stained in Meyer's
hematoxilin.
STATISTICS
n values given in Figure legends represent the number of
different animals from which organoids were prepared. For
every experimental condition at least eight sections of each
organoid were analysed. Data were statistically analysed
by ANOVA and expressed as means ±SD, and statistically
significant differences are indicated in the Figures. The pro-
liferation index was calculated as mean number of labelled
cells/total cell population and section.
Results
The time course of medial SMC proliferation which
occurred in vitro following endothelial denudation of
aortic organoids was compared with that occurring in vivo
after ballooning of carotid arteries. In carotid arteries,
maximum medial proliferation was achieved within 3 days
post-ballooning and thereafter decreased progressively to
reach a baseline proliferation index post-ballooning
(Fig. 1). In cultured aortic organoids, medial proliferation
reached maximum 7 days after endothelial denudation and
then decreased to baseline after 14 days in culture (Fig. 1).
A negligible medial proliferative response was observed
(labelling indices not significantly different from day 0;
data not shown) when organoids were cultured for up to 14
days under completely serum-free conditions (i.e. 1% PDS
ND
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Figure 1 Comparison of [3H]-thymidine incorporation into
medial SMC either in vivo following balloon catheterization of rat
carotid arteries (solid bars), or in vitro following endothelial-
denudation of aortic tissue rings (hatched bars). Data are given as
mean ± SD, n = 10; *P < 005; **P s 0001; ns = not significant;
ND = labelling index of organoids after 28 days in culture not
determined.
replaced by 1% bovine serum albumin). In the presence of
1% PDS the maximal medial SMC proliferation index
achieved in de-endothelialized aortic organoids was only
—40% of that observed in vivo following ballooning of
carotid arteries.
To investigate the role of the endothelium in SMC pro-
liferation in aortic organoids, [3H]-thymidine incorpora-
tion into medial SMC of intact and de-endothelialized
aortic rings was measured after 3 and 7 days of culture
under basal conditions (OptiMEM/1% PDS). Analysis at
day 14 was not routinely included because proliferation
indices had returned to baseline by this time (see Fig. 1). In
organoids with an intact endothelium the proliferation
index did not exceed 1% at either of the culture periods
(Fig. 2). [3H]-thymidine labelling of medial SMC in
endotheliutn-denuded organoids was 5-6 fold greater then
in intact organoids (P < 0-001 for proliferation index at
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Figure 2 [3H]-thymidine incorporation into medial SMC after 3
and 7 days of culture of either intact (solid bars,) or endothehum-
denuded aortic organoids (hatched bars). Data are given as
mean ± SD, n = 8; *P < 005; **P £ 0001; ns = not significant.
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Figure 3 [3H]-thymidine incorporation into medial SMC in intact
aortic organoids was measured after 3 and 7 days culture under
basal conditions (1% PDS; solid bars) or with inclusion of Ang II
(hatched bars) or the combination of Ang II and cilazaprilat (open
bars). Organoids were obtained from ACE inhibitor-pretreated
rats. Data are given as mean ± SD, n = 6; *P < 005; **P < 0001;
ns = not significant.
either 3 or 7 days; Fig. 2). Some proliferation of adventitial
fibroblasts and also eventually of endothelial cells (day 14)
was observed (data not included in this paper).
Figures 3 and 4 present data for medial proliferation in
organoids from cilazapril treated animals following culture
under control conditions (OptiMEM/1% PDS) and with
inclusion of either 10"7M Ang II or a combination of Ang II
and cilazaprilat. Cilazapril treatment of animals per se did
not significantly influence basal medial SMC proliferation
in either intact or endothelium-denuded rings (compare
control values in Figs 3 and 4 with data fom untreated ani-
mals in Fig. 2). In intact organoids from cilazapril-treated
animals, inclusion of 10"2M Ang II significantly elevated
medial proliferation indices compared to unstimulated
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Figure 4 [3H]-thymidine incorporation into medial SMC in
endothelium-denuded aortic organoids was measured after 3 or 7
days culture under basal conditions (1% PDS; solid bars) or with
inclusion of Ang II (hatched bars) or Ang II/cilazaprilat (open
bars). Organoids were obtained from ACE inhibitor-pretreated
rats. Data are given as mean ± SD, n = 10; *P rs 005; **P £ 0001;
ns = not significant.
controls after both 3 days (P < 0-05) and 7 days
(P < 0001) in culture (Fig. 3). Ang II also induced [3H]-
thymidine labelling in endothelium-denuded organoids
(P < 0-05 at day 3 and P < 0-001 at day 7; Fig. 4), although
due to the elevated basal proliferation index in these
organoids the relative stimulatory effect of Ang II (fold-
increase above basal was 0-6 and 1-3 at days 3 and'7,
respectively Fig. 4) was less than in intact organoids
(fold-increase above basal was 1-8 and 5-4 at days 3 and 7,
respectively; Fig. 3). It is noteworthy that the absolute
labelling indices after 7 days culture in the presence of
Ang II did not differ significantly between intact
(3-7 ± 0-4) and de-endothelialized (4-4 ± 0-3) tissues.
When PDS in culture medium was replaced by 1% bovine
serum albumin the stimulatory effects of Ang II on
[3H]-thymidine labelling in intact and de-endothelialized
organoids was not observed (data not shown).
For organoids cultured in the combined presence of
Ang II and cilazaprilat, medial [3H]-thymidine labelling
was greater than that in control organoids (P < 0001
at day 7), but did not achieve that level observed in
organoids exposed only to Ang II (P < 0-001 at day 7)
(Fig. 3). In contrast, for de-endothelialized organoids
labelling indices in controls and those cultured in the
combined presence of Ang II and cilazaprilat were not
significantly different (Fig. 4).
Discussion
The present study has demonstrated that mechanical
endothelial denudation of aortic organoids in vitro results
in medial SMC proliferation which is comparable, in terms
of early onset and transience, to the proliferative response
observed in vivo following ballooning of the carotid artery.
For the purposes of investigating the autoregulative
capacity of a vessel and its modulation by defined external
stimuli (e.g. growth modulators or pharmacalogical com-
pounds), our in vitro organoid model is advantageous in
that confounding systemic and neuronal influences present
in vivo are absent.
The occurrence of SMC medial proliferation in cultured
organoids required inclusion of minimal levels of serum
(1% plasma-derived serum) during culture. Additionally,
comparison of the [3H]-thymidine labelling indices in
either intact or endothelium-denuded organoids revealed a
conspicuous protective effect of the endothelium on
medial SMC proliferation. This may indicate that in intact
organoids, either medial SMC are relatively (vs endothe-
lium-denuded organoids) inaccessible to PDS-contained
growth-promoting factors or that the endothelium might
constitutively release negative-growth regulatory factors
which counter the mitogenic activities contained in PDS.
However, PDS is an essentially mitogen-free preparation
of serum'7', as demonstrated by its minimal support of the
growth of isolated SMC in culture (methods and refs.'7-81).
In vivo it has been shown that after endothelial denudation
of the carotid artery by ballooning, metalloproteases
within the media are activated'91 with resultant depolymer-
ization of the extracellular matrix, proteolytic degradation
of extracellular matrix constituents and the release of bio-
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logically active degradation products (e.g. EGF-like
peptides) which can synergistically support SMC proli-
feration'101. It is thus possible that the mitogenic activity
of PDS in endothelium-denuded organoid cultures may
also arise from medial SMC-induced activation of
PDS-containing latent growth-promoting substances.
Mesenchymal proliferation is unlikely to be due to an
unspecific wound-healing response to endothelium-
denudation since negligible mesenchymal proliferation
was detected in unstimulated controls.
The protective effect of the endothelium was also evi-
dent when organoids derived from cilazapril-treated ani-
mals were cultured under conditions of continuous in vitro
angiotensin converting enzyme inhibition, indicating that
the negative growth-modulatory effect of the endothelium
is not linked to the local renin-angiotensin system.
Moreover, the stimulatory effect of Ang II on SMC prolif-
eration (i.e. the several-fold-increase of labelling above
control proliferation indices) was greatest in intact
organoids. This further supports the argument that the pro-
tective effect of the endothelium does not relate to inhibi-
tion of the effects of Ang II. In vivo, Ang II has been
demonstrated to act as a long-term mitogen1"1, an effect
proposed to involve co-mediatory effects of the /J-adrener-
gic system'11'. Our findings that Ang II stimulates medial
SMC proliferation in cultures of aortic organoids, where
co-participation of the j3-adrenergic system is absent,
would, however, indicate that the growth promoting
activity of Ang II is independent of the nervous system.
There was no medial SMC proliferation response to Ang
II in either intact or endothelium-denuded organoids
under completely serum-free culture conditions indicating
a requirement for some co-mitogenic factor(s) present in
plasma-derived serum. The effect of Ang II on SMC pro-
liferation in organoids not only requires the presence of
PDS but was also greatest in intact organoids. These data
suggest that either PDS stimulates the release of endothe-
lium-derived factors, which, per se, are minimally effective
in promoting SMC growth but which can synergize with
Ang II, or that Ang II itself promotes release of co-mito-
genic factors from the endothelium. Since endothelium-
denuded organoids exhibited a significant SMC growth
response to Ang II, the ability of Ang II to promote medial
SMC proliferation is, however, not necessarily dependent
on endothelium-derived growth promoting factors.
The proliferative response of organoids cultured in the
combined presence of Ang II and cilazaprilat was weaker
than that of organoids exposed to Ang II alone, and this
difference was highly significant in intact organoids. Since
the presence of cilazaprilat during culture cannot signifi-
cantly alter the effective concentrations of Ang II (10~7M
already present) the blunted proliferative response of Ang
II/cilazaprilat (vs Ang II alone) in cultured organoids may
reflect an action of cilazapril that is unrelated to inhibition
of angiotensin converting enzyme. The contribution of
elevated tissue bradykinin to this phenomenon can be
excluded since exogenously added bradykinin did not
mimic Ang II-mediated effects (labelling index less than 1)
and neither was Ang II-stimulated mitogenesis inhibited
by bradykinin antagonist (labelling index = 5). Since the
negative effect of cilazaprilat on medial SMC proliferation
is more pronounced in intact than endothelium-denuded
organoids, an endothelium-dependent mode of action, pos-
sibly the release of growth-inhibitory substances for this
compound, is implied. Importantly, although Ang II stimu-
lates medial SMC proliferation in endothelium-denuded
organoids, this proliferation response is no longer manifest
in organoids cultured in the combined presence of Ang II
and cilazaprilat. Thus cilazaprilat also exerts endothelium-
independent effects. It is not yet known whether these
effects related to inhibition of metalloproteases other than
angiotensin converting enzyme (e.g. medial SMC enzymes
which activate latent serum or extracellular matrix factors).
The data herein illustrate the complex and powerful reg-
ulation of medial SMC proliferation by the endothelium.
Several candidate categories of endothelium-derived sub-
stances such as NO, prostanoids, and peptides are likely to
be involved. The culture of aortic organoids should provide
a useful model for investigating the growth-regulatory
potential of specific endothelium-derived substances, as
well as their interactions with one another.
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